Active

CRG

Investor type

PE

Founded

2003

AUM

$4 000 M

Location

Houston, Texas, United States

Investment Ticket

$10-50 m

Investment Stage

Series B Late Stage (Series C+)

Region of investment

North America Europe
Investor profile last updated: 19 September, 2025

Profile

CRG is a premier healthcare-focused investment firm that has managed over $3 billion of institutional capital since inception and its senior investment professionals have led over 70 investments. The firm seeks to commit between $20 to $300 million in each investment across the healthcare spectrum, including: medical devices, biopharmaceuticals, tools & diagnostics, services and information technology. CRG provides growth capital in the form of long-term debt and equity to support innovative, commercial-stage healthcare companies that address large, unmet medical needs. The firm partners with public and private companies to provide flexible financing solutions and world-class support to achieve exceptional growth objectives with minimal dilution. CRG maintains offices in Boulder, New York and Houston. For additional information, please visit www.crglp.com.

Industry

Healthcare Services Medical Devices Pharmaceuticals MedTech Life Sciences Consumer Products Consumer Services (B2C)

CRG Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Capital Royalty Partners II
Private Equity (PE)
Healthcare Services
Medical Devices
Life Sciences
Series B
Late Stage (Series C+)
North America
South America
Europe
Middle East
Africa
Asia
Australia and others
$5-10 m
$805 M
May 2013
CRG Partners III
Private Equity (PE)
Healthcare Services
Medical Devices
Series B
Late Stage (Series C+)
North America
$5-10 m
$1500 M
January 2017
CRG Partners I LP
Private Equity (PE)
Consumer Products
Consumer Services (B2C)
Healthcare Services
Medical Devices
Series B
Late Stage (Series C+)
North America
$5-10 m
$325 M
June 2003
CRG Partners IV LP
Private Equity (PE)
Consumer Products
Consumer Services (B2C)
Healthcare Services
Medical Devices
Series B
Late Stage (Series C+)
North America
$5-10 m
$1400 M
November 2017

Contacts

Name
Title
Email
Upgrade to see contacts
avatar
M1OStUjoTkbACZfi M1OStUjoTkbACZfi
M1OStUjoTkbACZfi
avatar
M1OStUjoTkbACZfi M1OStUjoTkbACZfi
M1OStUjoTkbACZfi
avatar
M1OStUjoTkbACZfi M1OStUjoTkbACZfi
M1OStUjoTkbACZfi
avatar
M1OStUjoTkbACZfi M1OStUjoTkbACZfi
M1OStUjoTkbACZfi
avatar
M1OStUjoTkbACZfi M1OStUjoTkbACZfi
M1OStUjoTkbACZfi
Investment-team contacts for CRG — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about CRG

CRG is a private equity firm. It backs companies at Series B and Late Stage (Series C+), writing tickets of $10-50 m.
CRG is located in Houston, Texas, United States.
CRG was founded in 2003.
CRG invests in companies and startups in Healthcare Services, Medical Devices, Pharmaceuticals, MedTech, Life Sciences, Consumer Products, Consumer Services (B2C).
CRG invests in companies and startups in North America, Europe.
CRG invests in companies and startups at Series B, Late Stage (Series C+).
CRG usually invests $10-50 m on average.
CRG has around $4 000m assets under management.
CRG last fund was created/launched in 2017-11-10
CRG can be reached through its website crglp.com and its LinkedIn page. Its general enquiries address is crgir@crglp.com. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for CRG — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query CRG directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 19 September, 2025. Something out of date here? Report it — we re-run that firm within 48h and get back to you.